» Articles » PMID: 6848831

Hepatic Injury Possibly Induced by Verapamil

Overview
Journal JAMA
Specialty General Medicine
Date 1983 Jan 21
PMID 6848831
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience.

Ekhlaspour L, Buckingham B, Bauza C, Clements M, Forlenza G, Neyman A J Clin Transl Endocrinol. 2024; 36:100352.

PMID: 38860154 PMC: 11163172. DOI: 10.1016/j.jcte.2024.100352.


Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.

Lehnert M, Mross K, Schueller J, Thuerlimann B, Kroeger N, Kupper H Br J Cancer. 1998; 77(7):1155-63.

PMID: 9569055 PMC: 2150143. DOI: 10.1038/bjc.1998.192.


Verapamil-induced hepatotoxicity.

Kumar K, Colley C West J Med. 1994; 160(5):485-6.

PMID: 8048248 PMC: 1022510.


Liver damage from verapamil.

Guarascio P, DAmato C, Sette P, Conte A, Visco G Br Med J (Clin Res Ed). 1984; 288(6414):362-3.

PMID: 6419928 PMC: 1444247. DOI: 10.1136/bmj.288.6414.362-a.


Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.

Caruana M, Heber M, Brigden G, Raftery E Eur J Clin Pharmacol. 1987; 32(6):549-53.

PMID: 3653223 DOI: 10.1007/BF02455986.